Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Luminescence ; 28(4): 442-9, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23348981

RESUMEN

Glutamine is an important amino acid for immune function. Though high intensity and prolonged exercise decreases plasma glutamine concentration and causes immune suppression, the relationship between neutrophil functions and glutamine has not yet been found. The purpose of this study was to investigate the impacts of glutamine supplementation on neutrophil function. Twenty-six male university judoists were recruited. Subjects were classified into glutamine and control groups. The glutamine group ingested 3000 mg of glutamine per day and the control group ingested placebo for 2 weeks. Examinations were performed at the start of preunified loading exercise (pre-ULE), then 1 and 2 weeks after ULE (post-ULE). Reactive oxygen species (ROS) production, phagocytic activity, serum opsonic activity and serum myogenic enzymes were measured. Differences between the levels obtained in pre-ULE and post-ULE for the two groups were compared. In the glutamine group, ROS production activity increased 1 week after ULE, whereas it was not observed in the control group (P < 0.001). Though myogenic enzymes increased significantly after ULE (P < 0.001), the glutamine group remained unchanged by supplementation during ULE. Glutamine supplementation has prevented excessive muscle damage and suppression of neutrophil function, especially in ROS production activity, even during an intensive training period.


Asunto(s)
Suplementos Dietéticos , Glutamina/administración & dosificación , Glutamina/farmacología , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Glutamina/inmunología , Humanos , Masculino , Proteínas Opsoninas/sangre , Fagocitosis/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Adulto Joven
2.
J Nutr Sci Vitaminol (Tokyo) ; 55(1): 15-21, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19352059

RESUMEN

It has been reported that treatment with a pharmacological dose (45 mg/d) of menaquinone-4 (MK-4) prevents bone loss in postmenopausal women. However, it is not known whether supplementation with low dose MK-4 has beneficial effects on bone metabolism in healthy women. The aim of this study is to examine the effects of the supplementation of 1.5 mg/d MK-4 for 4 wk on bone and lipid metabolism in healthy postmenopausal Japanese women. The study was performed as a randomized double blind placebo-controlled trial. The participants aged 53-65 y were randomly assigned to 2 groups and supplemented with 1.5 mg/d of MK-4 or a placebo for 4 wk (n=20 for each group). The most marked effects of MK-4 intake were observed on serum osteocalcin (OC) concentrations. Serum undercarboxylated OC (ucOC) concentration decreased, and the gamma-carboxylated OC (GlaOC) and GlaOC/GlaOC+ucOC ratio that indicates the degree of OC gamma-carboxylation increased significantly at 2 and 4 wk compared with that at baseline in the MK-4 group. The serum ucOC and GlaOC concentrations in the MK-4 group were significantly different from those in the placebo group at 2 wk. These results suggest that supplementation with 1.5 mg/d MK-4 accelerated the degree of OC gamma-carboxylation. The concentrations of serum lipids and other indices were not different between the groups at either intervention period. Thus, the additional intake of MK-4 might be beneficial in the maintenance of bone health in postmenopausal Japanese women.


Asunto(s)
Huesos/efectos de los fármacos , Suplementos Dietéticos , Lípidos/sangre , Osteocalcina/sangre , Osteoporosis Posmenopáusica/tratamiento farmacológico , Vitamina K 2/uso terapéutico , Vitaminas/uso terapéutico , Biomarcadores/sangre , Presión Sanguínea/efectos de los fármacos , Huesos/metabolismo , Método Doble Ciego , Estradiol/sangre , Femenino , Humanos , Japón , Persona de Mediana Edad , Osteoporosis Posmenopáusica/sangre , Posmenopausia/sangre , Vitamina D/análogos & derivados , Vitamina D/sangre , Vitamina K 1/sangre , Vitamina K 2/sangre , Vitamina K 2/farmacología , Vitaminas/sangre
3.
Biosci Biotechnol Biochem ; 67(9): 1857-63, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-14519967

RESUMEN

In female SD rats that were injected with 4 g/kg BW ethanol p.o. followed by a 5 mg/kg BW lipopolysaccharide (LPS) i.v. injection, serum glutamic pyruvic transaminases (GPT) activity increased to about eight times that of normal rats. In this model, rats that had been fed a diet containing 1% Hydrangeae Dulcis Folium (HDF) extracts for fifteen days showed significantly lower serum GPT activity (380.0+/-58.2 IU/l) than the control group (3527.0+/-774.1 IU/l). HDF's efficacy was far superior to milk thistle in this model (2950.0+/-915.9 IU/l). When mouse macrophages were treated with HDF extracts at 50 microg/ml, TNF-alpha production induced by LPS was suppressed to about 10% of the control. Rat serum TNF-alpha levels induced by LPS was decreased to 58.7% of the control by administering 1000 mg/kg BW HDF extract p.o. These results indicate that HDF prevents alcohol-induced liver injury through the inhibition of TNF-alpha production.


Asunto(s)
Etanol/antagonistas & inhibidores , Hydrangeaceae/química , Lipopolisacáridos/antagonistas & inhibidores , Hepatopatías/prevención & control , Extractos Vegetales/farmacología , Alanina Transaminasa/sangre , Alimentación Animal , Animales , Peso Corporal/efectos de los fármacos , Línea Celular , Enfermedad Hepática Inducida por Sustancias y Drogas , Suplementos Dietéticos , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Escherichia coli/química , Escherichia coli/genética , Etanol/toxicidad , Femenino , Lipopolisacáridos/toxicidad , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Hepatopatías/enzimología , Hepatopatías/patología , Macrófagos/metabolismo , Ratones , Silybum marianum/química , Ratas , Ratas Sprague-Dawley , Factor de Necrosis Tumoral alfa/biosíntesis
4.
Biosci Biotechnol Biochem ; 67(12): 2641-3, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14730144

RESUMEN

Hydrangeae Dulcis Folium, the fermented and dried leaves of Hydrangea macrophylla SER. var. thunbergii MAKINO, suppressed D-galactosamine-induced liver injury by 85.2% when added to the diet at 1% and fed to rats for fifteen days. The hepatoprotective effect is more potent than that of a milk thistle extract and turmeric powder. Some fractionated extracts showed hepatoprotective activity in the D-galactosamine-induced in vitro liver injury model.


Asunto(s)
Alanina Transaminasa/análisis , Hydrangea/química , Hepatopatías/tratamiento farmacológico , Hígado/efectos de los fármacos , Fitoterapia , Alanina Transaminasa/sangre , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas , Galactosamina/toxicidad , Hígado/lesiones , Extractos Vegetales/química , Extractos Vegetales/farmacología , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA